Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chappell

Showing results (71-80 of 115) with videos related to

Pageof 12
Sort By:
Journal of Neurotrauma|November 1, 2001
Talampanel, a novel noncompetitive AMPA antagonist, is neuroprotective after traumatic brain injury in ratsL Belayev, O F Alonso, Y Liu, et al.
Pain Practice : the Official Journal of World Institute of Pain|July 7, 2010
A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the kneeAmy S Chappell, Durisala Desaiah, Hong Liu-Seifert, et al.
Pain Medicine (Malden, Mass.)|October 17, 2007
Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a reviewAmy M Barrett, Melanie A Lucero, Trong Le, et al.
Diabetes Care|March 1, 2007
Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic painDan Ziegler, Yili L Pritchett, Fujun Wang, et al.
The Veterinary Record|April 23, 1999
Nalidixic acid resistance in salmonellae isolated from turkeys and other livestock in Great BritainR H Davies, C J Teale, C Wray, et al.
The Clinical Journal of Pain|June 23, 2009
Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorderLesley M Arnold, James I Hudson, Fujun Wang, et al.
Clinical Pharmacology and Therapeutics|October 3, 2000
Effects of the 2-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid/kainate antagonist LY293558 on spontaneous and evoked postoperative painI Gilron, M B Max, G Lee, et al.
Pain|February 4, 2014
Safety, tolerability, pharmacokinetics, and effects on human experimental pain of the selective ionotropic glutamate receptor 5 (iGluR5) antagonist LY545694 in healthy volunteersKarin L Petersen, Smriti Iyengar, Amy S Chappell, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|December 4, 2009
Efficacy of duloxetine in patients with fibromyalgia: pooled analysis of 4 placebo-controlled clinical trialsLesley M Arnold, Daniel J Clauw, Madelaine M Wohlreich, et al.
Clinical Science (London, England : 1979)|August 1, 1988
Calcium retention and increased vascular reactivity caused by a hypothalamic sodium transport inhibitorM A Mir, K Morgan, S Chappell, et al.
Pageof 12

Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Journal of Neurotrauma|November 1, 2001
Talampanel, a novel noncompetitive AMPA antagonist, is neuroprotective after traumatic brain injury in ratsL Belayev, O F Alonso, Y Liu, et al.
Pain Practice : the Official Journal of World Institute of Pain|July 7, 2010
A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the kneeAmy S Chappell, Durisala Desaiah, Hong Liu-Seifert, et al.
Pain Medicine (Malden, Mass.)|October 17, 2007
Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a reviewAmy M Barrett, Melanie A Lucero, Trong Le, et al.
Diabetes Care|March 1, 2007
Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic painDan Ziegler, Yili L Pritchett, Fujun Wang, et al.
The Veterinary Record|April 23, 1999
Nalidixic acid resistance in salmonellae isolated from turkeys and other livestock in Great BritainR H Davies, C J Teale, C Wray, et al.
The Clinical Journal of Pain|June 23, 2009
Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorderLesley M Arnold, James I Hudson, Fujun Wang, et al.
Clinical Pharmacology and Therapeutics|October 3, 2000
Effects of the 2-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid/kainate antagonist LY293558 on spontaneous and evoked postoperative painI Gilron, M B Max, G Lee, et al.
Pain|February 4, 2014
Safety, tolerability, pharmacokinetics, and effects on human experimental pain of the selective ionotropic glutamate receptor 5 (iGluR5) antagonist LY545694 in healthy volunteersKarin L Petersen, Smriti Iyengar, Amy S Chappell, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|December 4, 2009
Efficacy of duloxetine in patients with fibromyalgia: pooled analysis of 4 placebo-controlled clinical trialsLesley M Arnold, Daniel J Clauw, Madelaine M Wohlreich, et al.
Clinical Science (London, England : 1979)|August 1, 1988
Calcium retention and increased vascular reactivity caused by a hypothalamic sodium transport inhibitorM A Mir, K Morgan, S Chappell, et al.
Pageof 12